UNSPSC 85641764: Supplement of left lower leg subcutaneous tissue and fascia with synthetic substitute, open approach

This classification denotes the group of activities that yields a surgical intervention or procedure to supplement of left lower leg subcutaneous tissue and fascia with synthetic substitute, open approach. This surgical intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 0JUP0JZ

UNSPSC 85641764 Supplement of left lower leg subcutaneous tissue and fascia with synthetic substitute, open approach is a Commodity code. The recent opportunities posted under this code show little alignment with its medical-device surgical-procedure scope. The source contains no solicitations for prosthetic materials, surgical implants, or tissue-supplement devices; instead, the opportunities tagged to this code focus on occupational health surveillance, pharmacy benefit management, temporary health professional staffing, independent medical evaluations for pension disability determinations, and surgical procedure carve-out benefit programs. The mismatch between the code's clinical description and the actual procurement activity suggests either miscoding in the state and local system or that this Commodity code is used inconsistently across issuing bodies for broader healthcare administration and benefits management.

The recent opportunities originate from diverse issuing bodies across multiple states—the City of Phoenix Retirement Office (Arizona), City of Long Beach (California), Washington State Department of Transportation, Harris County Juvenile Probation Department (Texas), Collier County Board of County Commissioners (Florida), and County of Santa Clara Health System (California)—with response dates ranging from September 25, 2026 through October 16, 2026. No single state dominates the activity, and the scope spans medical staffing, benefits administration, and occupational health programs rather than surgical implants or tissue-supplement procurement. State and local procurement activity under this code does not reflect its nominal commodity focus and presents no clear opportunity pipeline for vendors working in prosthetic devices or surgical substitutes.